Company: LENZ
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001815776-25-000056
Chunk: 342

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-07-30
Form: 10-Q
Item: Part II, Item 6
Chunk 342
---
 Presentation Linkbase Document104Cover Page Interactive Data File (embedded within the Inline XBRL document)

__________________

*The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the SEC and are not to be incorporated by reference into any filing of LENZ Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

83

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LENZ THERAPEUTICS, INC.Dated: July 30, 2025By:/s/ Evert SchimmelpenninkName:Evert SchimmelpenninkTitle:Chief Executive Officer(Principal Executive Officer)Dated: July 30, 2025By:/s/ Daniel ChevallardName:Daniel ChevallardTitle:Chief Financial Officer(Principal Financial and Accounting Officer)

84